Overall, our findings discussed above provide clear evidence that the distribution of CRHR2 in the inflamed colonic mucosa and the local availability of its selective agonist Ucn2, via an autocrine, or paracrine axis, determine in a large part the CRC response to inflammatory signals that support its survival, growth, and metastatic behavior. The gene discussed is CRHR2; the disease is colorectal carcinoma.